Children’s Somatization Inventory (SCI)

1. Abstract

The Children’s Somatization Inventory (CSI; also cited in clinical sourcebooks as the Children’s Somatization Inventory [SCI]) is a standardized, self-report psychometric instrument designed to assess the presence and severity of somatization and nonspecific functional somatic symptoms in pediatric populations aged 8 to 18 years. Originally developed by Lynn S. Walker, Judy Garber, and Joseph W. Greene in 1991, the instrument adapts symptom criteria derived from the Diagnostic and Statistical Manual of Mental Disorders (DSM-III/DSM-III-R) and the Hopkins Symptom Checklist (HSCL) into child-accessible language. The original full version comprises 35 symptom items—supplemented by two conditional female menstrual inquiries (yielding 37 questions total)—and assesses diverse physiological domains including gastrointestinal distress, cardiovascular reactions, pseudoneurological symptoms, and diffuse musculoskeletal pain. A psychometrically optimized 24-item short form (the CSI-24), validated by Walker et al. in 2009, refines the scale by eliminating low-frequency pseudoneurological items and optimizing invariant factor structures across clinical and community samples.

Each item evaluates symptom severity over a specified recall window (typically the preceding two weeks) on a 5-point Likert-type intensity scale ranging from 0 (“Not at all”) to 4 (“A whole lot”). Psychometric evaluations in both community cohorts and clinical samples—particularly youth with recurrent abdominal pain, irritable bowel syndrome, and chronic pain disorders—demonstrate robust internal consistency (Cronbach’s alpha typically exceeding .88 to .92 for the full inventory and .86 to .91 for the CSI-24), excellent test-retest stability, and compelling convergent validity with standardized measures of pediatric anxiety, depressive symptomatology, functional disability, and health care utilization. This article provides a comprehensive academic review of the scale’s purpose, psychological constructs, theoretical underpinnings, psychometric properties, structural validity, clinical administration guidelines, and authentic scale items.

2. Keywords

Children’s Somatization Inventory, CSI, CSI-24, pediatric somatization, functional somatic symptoms, somatic symptom disorder, chronic pediatric pain, recurrent abdominal pain, psychometrics, somatosensory amplification, Lynn S. Walker, child health psychology

3. Authors

The Children’s Somatization Inventory was primarily developed and validated through the collaborative pediatric psychology and child psychiatry research programs at Vanderbilt University and Vanderbilt University Medical Center in Nashville, Tennessee, USA. The core investigative team includes:

• Lynn S. Walker, Ph.D.: Professor Emerita of Pediatrics and Psychology, Division of Adolescent Medicine and Behavioral Sciences, Department of Pediatrics, Vanderbilt University School of Medicine. Dr. Walker is an internationally recognized pioneer in pediatric chronic abdominal pain, functional gastrointestinal disorders (FGIDs/Disorders of Gut-Brain Interaction), somatosensory processing, and longitudinal outcomes of childhood pain.
• Judy Garber, Ph.D.: Professor of Psychology and Human Development, Department of Psychology and Human Development, Peabody College, Vanderbilt University. Dr. Garber is an authority on the developmental psychopathology of childhood and adolescent depression, cognitive vulnerability, and family-based internalizing risk trajectories.
• Joseph W. Greene, M.D.: Professor of Pediatrics and Director of Adolescent Medicine, Vanderbilt University School of Medicine. Dr. Greene’s clinical expertise centered on adolescent health, psychosomatic illness, and pediatric primary care presentations of functional medical complaints.
• Jane E. Beck, Ph.D. (co-author on the revised CSI-24): Research psychologist and quantitative methodologist at the Division of Adolescent Medicine and Behavioral Sciences, Vanderbilt University Medical Center, instrumental in psychometric refinement and confirmatory factor modeling of the abbreviated inventory.

Correspondence regarding the development and historical psychometric validation of the CSI has historically been addressed to the Division of Adolescent Medicine and Behavioral Sciences, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

4. Purpose

The primary purpose of the Children’s Somatization Inventory is to provide a standardized, clinically sensitive, and psychometrically rigorous instrument for quantifying the frequency, multiplicity, and perceived distress of functional somatic complaints in youth. Somatization in children and adolescents represents a widespread, complex, and heterogeneous clinical phenomenon characterized by the persistent manifestation of physical complaints that cannot be fully explained by demonstrable organic pathology, structural abnormalities, or systemic physiological disease. In pediatric practice, physical symptoms such as recurrent stomachaches, persistent headaches, widespread musculoskeletal soreness, palpitations, and non-epileptic dizziness account for a substantial percentage of primary care visits and subspecialty pediatric referrals, including gastroenterology, neurology, and rheumatology.

In clinical settings, the CSI serves multiple complementary functions:

• Systematic Symptom Screening: It provides medical and behavioral health practitioners with an objective, standardized screen to assess whether a child’s complaints are localized to an isolated anatomical site (e.g., isolated epigastric pain) or represent a broader, diffuse pattern of systemic somatization spanning multiple biological systems.
• Differential Diagnosis and Risk Stratification: By measuring multisystem somatic burden, the scale aids in distinguishing between organ-specific organic pathophysiology and functional somatic symptom disorders or functional abdominal pain disorders (such as irritable bowel syndrome and functional dyspepsia), where perceived symptom burden frequently diverges markedly from objective biomedical markers.
• Treatment Planning and Outcome Monitoring: The CSI yields a continuous severity index that can track therapeutic gains over time in response to evidence-based interventions, such as cognitive-behavioral therapy (CBT), gut-directed hypnotherapy, acceptance and commitment therapy (ACT), and pharmacotherapy. Reductions in total CSI score frequently correlate with improved school attendance, decreased parental missed workdays, and restoration of developmental functioning.

In developmental and behavioral research, the CSI has become the gold-standard metric for testing biopsychosocial hypotheses regarding pediatric chronic illness. Research groups worldwide deploy the inventory to investigate the interactions among genetic predispositions, autonomic nervous system dysregulation, family illness modeling, parental catastrophizing, and central pain processing. By operationalizing somatic burden as a continuous, quantifiable construct rather than an all-or-nothing psychiatric categorical diagnosis, the inventory enables researchers to study both subclinical somatic distress in non-clinical community cohorts and severe somatic symptom presentations in tertiary subspecialty clinics.

5. Psychological Construct

The psychological construct captured by the Children’s Somatization Inventory is somatization—conceptualized in contemporary developmental psychopathology as the tendency to experience, express, and communicate psychological distress, autonomic arousal, or environmental stress in the form of physical bodily symptoms, paired with the seeking of medical care for these sensations. Historically, somatization carried narrow psychoanalytic connotations of unconscious “conversion” of psychological conflict into physical deficits. In modern psychometrics, developmental medicine, and the DSM-5 framework, somatization is operationalized more broadly as somatic symptom distress: the conscious, subjective perception of distressing, impairing bodily sensations that correlate closely with internalizing psychological symptoms (anxiety and depression) and altered neurobiological sensitivity.

The construct measured by the CSI encompasses multiple distinct physiological and sensory dimensions:

1. Gastrointestinal Symptoms

Gastrointestinal (GI) complaints represent the most prevalent somatic manifestations observed in pediatric populations. The CSI measures both upper and lower GI tract symptoms, including nausea or upset stomach (feeling like vomiting), persistent abdominal or stomach pain, loose stools/diarrhea, constipation, bloating/excess gas, and food-related postprandial sickness. These items capture the clinical presentations central to disorders of gut-brain interaction (DGBI), reflecting bidirectional signaling dysregulation between the central nervous system and the enteric nervous system.

2. Pain and Musculoskeletal Symptoms

This dimension assesses diffuse, non-articular and articular physical pain across diverse anatomical regions, including headaches, lower back pain, sore muscles, and bilateral or migratory joint aches (knees, elbows, arms, and legs). In children, high endorsement of non-abdominal musculoskeletal pain along with primary abdominal complaints often signals generalized somatic hyperalgesia or juvenile central sensitivity syndromes (e.g., juvenile fibromyalgia) rather than a localized orthopedic or rheumatologic condition.

3. Autonomic and Cardiorespiratory Dysregulation

The scale incorporates autonomic manifestations indicative of physiological hyperarousal, sympathetic nervous system overactivity, and hyperventilation. These include faintness or dizziness, palpitations (heart beating rapidly when not exercising), non-exertional chest or heart pain, dyspnea (trouble getting one’s breath without physical exertion), and vasomotor instability manifested as sudden hot or cold spells.

4. Pseudoneurological and Conversion Symptoms

Deriving from historical DSM-III criteria for somatization disorder, the full 35-item scale includes items assessing pseudoneurological functional neurological symptom phenomena: numbness, tingling sensations (paresthesias), subjective extremity weakness, heavy feelings in limbs, globus sensation (“lump in your throat”), aphonia (loss of voice), diplopia (double vision), blurred vision, psychogenic blindness, psychogenic non-epileptic seizures/convulsions, amnesia, and gait disturbances. While relatively infrequent in healthy community youth, these items show high specificity in tertiary neuropsychiatric and adolescent medical settings.

5. Constitutional and Asthenic Symptoms

General constitutional distress is evaluated through items measuring lethargy, persistent fatigue, feeling low in energy or slowed down, and pervasive bodily heaviness, capturing the profound overlap between severe somatization, internalizing distress, and chronic fatigue syndromes in adolescence.

6. Theoretical Framework

The Children’s Somatization Inventory is rooted in the biopsychosocial model of health and illness pioneered by George L. Engel (1977), integrated with contemporary models of somatosensory amplification, social learning theory, and cognitive appraisal and coping in childhood.

1. The Biopsychosocial and Diathesis-Stress Model

Rather than conceptualizing somatic symptoms as either purely “organic” or purely “psychogenic,” Walker and colleagues posited that childhood somatic complaints emerge from dynamic, reciprocal interactions between biological vulnerabilities, psychological traits, and social environments. Biological diatheses—such as innate visceral hypersensitivity, hypervigilant autonomic reactivity, altered central pain processing, or history of an acute infection (e.g., post-infectious gastroenteritis)—interact with psychological vulnerabilities (e.g., high trait negative affectivity, neuroticism, or anxiety sensitivity). When confronted with interpersonal, academic, or familial stressors, these vulnerable youths experience amplified physiological responses that are cognitively perceived as threatening somatic illness.

2. Somatosensory Amplification and Attentional Biases

The scale draws upon the somatosensory amplification framework proposed by Arthur J. Barsky and Gerald L. Klerman (1989). Somatosensory amplification involves the tendency to experience somatic sensations as intense, noxious, and alarming. According to this framework, somatic symptom severity reflects three intertwined cognitive-perceptual components: hypervigilant bodily scanning (attentional allocation directed inward toward minor visceral cues), cognitive catastrophic appraisal (interpreting benign sensations like normal digestive contractions or fatigue as indicators of impending physical disaster), and behavioral avoidance, which prevents extinction and perpetuates physical disability.

3. Social Learning and Family Systems Theory

A central theoretical premise confirmed across empirical studies by Walker, Garber, and Greene (1991, 1993) is that pediatric somatization is heavily modeled, reinforced, and maintained within the family system. Children frequently observe and internalize illness behavior demonstrated by parents with high rates of somatization, chronic pain, or psychiatric distress. Furthermore, parental protective responses to child somatic symptoms—such as excessive inquiry, encouraging school absenteeism, providing secondary gain (e.g., exemption from chores, unrestricted access to screens), and conveying heightened health anxiety—unintentionally reinforce somatic complaints and solidify a sick-role identity.

4. Cognitive Appraisal and Coping Theory

Expanding Richard Lazarus and Susan Folkman’s transactional model of stress and coping, Walker et al. (2005) established that the trajectory of pediatric functional pain into long-term functional disability is mediated by the child’s cognitive appraisal. Children who appraise bodily sensations as threatening and uncontrollable, engaging in passive, catastrophizing coping mechanisms (e.g., self-isolation, catastrophizing thoughts), report dramatically higher scores on the CSI and exhibit elevated functional impairment compared to children who employ adaptive, problem-solving, or accommodative coping strategies.

7. Validity

The Children’s Somatization Inventory has undergone extensive psychometric validation across three decades in diverse pediatric cohorts, establishing robust construct, convergent, discriminant, and predictive validity.

1. Construct and Structural Validity

Construct validity was initially established by Walker, Garber, and Greene (1991) by demonstrating that pediatric patients presenting with recurrent abdominal pain (RAP) scored significantly higher on the total CSI compared to age-matched healthy community control children. In subsequent developmental studies, Garber, Walker, and Zeman (1991) confirmed that the inventory captured a coherent continuum of somatic distress across non-clinical school cohorts, with older adolescents (particularly females) demonstrating elevated symptom levels mirroring adult epidemiological patterns of functional somatic symptoms.

2. Convergent Validity

The CSI exhibits strong, statistically significant positive correlations with validated self-report and parent-proxy measures of childhood emotional distress:

• Pediatric Anxiety: Total CSI scores correlate strongly with measures such as the Revised Children’s Manifest Anxiety Scale (RCMAS; $r = .50$ to $.65$, $p < .001$) and the Multidimensional Anxiety Scale for Children (MASC;$r = .48$ to $.62$), reflecting the intense cross-sectional coupling between internalizing autonomic hyperarousal and somatic complaints.
• Depressive Symptomatology: Scores correlate substantially with the Children’s Depression Inventory (CDI; $r = .45$ to $.60$, $p < .001$). Children who report multiple unexplained physical complaints frequently endorse dysphoria, fatigue, anhedonia, and vegetative depressive features.
• Functional Disability: CSI scores exhibit strong positive associations with the Functional Disability Inventory (FDI; $r = .52$ to $.68$, $p < .001$), confirming that youth with higher somatic burden suffer proportional impairment in daily physical, academic, and social functioning.

3. Discriminant and Criterion Validity

Walker, Garber, and Greene (1993) demonstrated critical discriminant validity by comparing three distinct pediatric cohorts: patients with functional recurrent abdominal pain (RAP), patients with documented organic gastrointestinal diseases (e.g., Crohn’s disease, ulcerative colitis, peptic ulcer disease), and pediatric patients with diagnosed psychiatric internalizing disorders. Although patients with organic disease suffered severe objective intestinal pathology, their scores on non-gastrointestinal CSI items were significantly lower than those of functional RAP patients. Patients with functional pain exhibited diffuse somatic complaints extending far beyond the abdomen (e.g., headaches, dizziness, joint aches, paresthesias), proving that the CSI discriminates diffuse functional somatization from localized organic pathology.

4. Predictive and Longitudinal Validity

Longitudinal studies demonstrate that baseline CSI scores strongly predict long-term clinical trajectories. Elevated CSI scores in childhood predict persistent chronic pain, elevated functional impairment, frequent school absenteeism, and high health care utilization rates (ambulatory visits, emergency department presentations, and invasive diagnostic testing) at 1-year, 5-year, and adult follow-ups spanning up to 15 years post-initial clinical presentation (Walker et al., 2005).

8. Reliability

The reliability of both the original 35-item CSI and the revised 24-item CSI (CSI-24) has been demonstrated through internal consistency analyses, test-retest assessments, and cross-informant concordance tests across clinical and epidemiological investigations.

1. Internal Consistency

The internal consistency of the CSI is consistently high across independent research groups, languages, and developmental stages:

• Original 35-item Form: In the initial validation study by Walker, Garber, and Greene (1991), Cronbach’s alpha ($lpha$) for the total scale was .89 in pediatric abdominal pain patients and .92 in a concurrent community control sample. Garber, Walker, and Zeman (1991) confirmed an alpha of .92 in an expanded community sample of 540 children and adolescents.
• Revised 24-item Form (CSI-24): In the definitive psychometric refinement study by Walker, Beck, Garber, et al. (2009), the CSI-24 demonstrated excellent reliability across both clinical pain cohorts ($lpha = .88$) and community cohorts ($lpha = .89$). Item-total correlations for retained items generally range from $.35$ to $.68$.

2. Test-Retest Reliability

Temporal stability assessments have demonstrated moderate-to-high test-retest reliability across various testing intervals:

• Over a two-week to one-month interval in stable, untreated community samples, Pearson product-moment correlation coefficients ($r$) range between .70 and .83, indicating that individual differences in general somatization tendencies remain robustly stable over short durations.
• Over extended 3-month to 6-month follow-ups in clinical intervention studies, test-retest correlations fall to approximately $.45$ to $.60$, accurately reflecting real clinical fluctuation, symptom remission, or treatment-associated reductions in functional somatic distress.

3. Inter-Rater and Cross-Informant Agreement

Parent-proxy versions of the CSI (where mothers or fathers independently complete the inventory regarding their child’s symptoms) correlate moderately with child self-reports ($r = .40$ to $.55$, $p < .001$). This level of concordance aligns with standard developmental psychopathology findings for internalizing symptoms: parents often observe visible behavioral manifestations (e.g., vomiting, limp, verbal complaints of stomachache) but systematically underreport covert, internal sensory phenomena (e.g., faintness, paresthesias, blurred vision) compared to the youth's direct subjective experience.

9. Factor Analysis

The internal factor structure of the Children’s Somatization Inventory has been rigorously examined using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA), leading directly to the contemporary psychometric preference for the CSI-24.

1. Exploratory Factor Analysis of the 35-Item Version

In early exploratory factor analytic studies conducted on the 35-item inventory (Garber et al., 1991; Walker et al., 1991), principal components analyses frequently extracted multi-factor solutions comprising between 4 and 7 latent factors. These empirically observed factors mapped closely onto distinct anatomical domains: gastrointestinal symptoms (nausea, stomach pain, vomiting, diarrhea), autonomic/cardiorespiratory reactivity (palpitations, shortness of breath, dizziness), general musculoskeletal pain (sore muscles, back pain, joint pain), and pseudoneurological symptoms (paralysis, blindness, amnesia, seizures).

However, these exploratory factors exhibited high inter-factor correlations (frequently $r > .50$), and a large general factor accounted for the single greatest proportion of total variance. Furthermore, many severe conversion/pseudoneurological items (such as deafness, blindness, loss of voice, and difficulty walking) exhibited extremely low endorsement base rates in both community and primary care pediatric settings, leading to severe floor effects, positive skewness, and unstable factor loading patterns across diverse developmental strata.

2. Confirmatory Factor Analysis and the CSI-24 Revision

To address structural stability issues, Walker, Beck, Garber, et al. (2009) conducted a comprehensive CFA study involving a clinical sample of 882 pediatric abdominal pain patients and an independent community sample of 865 school-aged children. CFA indicated that the original 35-item scale had suboptimal fit when subjected to rigorous structural equation modeling, primarily attributable to the 11 low-frequency items.

Through systematic psychometric pruning, Walker et al. eliminated 11 items that demonstrated near-zero variance, severe distribution skewness, or poor item-total correlations across groups. The remaining 24 items (designated as the CSI-24) were modeled. Multiple factor models were systematically tested:

• Unidimensional General Factor Model: A single global “Somatization” latent factor demonstrated excellent fit to the empirical data across both clinical and non-clinical samples. Fit indices in the confirmatory sample met standard benchmarks: Comparative Fit Index ($CFI = .94$ to $.96$), Tucker-Lewis Index ($TLI = .93$ to $.95$), and Root Mean Square Error of Approximation ($RMSEA = .042$ to $.049$, $90%\text{ CI } [0.038, 0.051]$).
• Bifactor Model: Bifactor analyses revealed that while minor specific group factors (GI, Pain/Musculoskeletal, Cardiorespiratory) exist, the general somatization factor accounted for over $75%$ of the common variance ($\omega$ hierarchical, $\omega_h > .80$).

Consequently, the authors and subsequent psychometric guidelines recommend scoring the CSI-24 primarily as a single, unidimensional composite score representing the child’s overall functional somatic symptom burden.

10. Instrument / Measurement Tool

The operational characteristics and structural specifications of the Children’s Somatization Inventory are detailed below:

• Instrument Type: Standardized pediatric self-report rating scale (parallel parent-proxy report version available).
• Target Population: Children and adolescents aged 8 through 18 years.
• Estimated Administration Time: Approximately 5 to 10 minutes for child self-administration.
• Item Formats and Inventory Versions:
  • Full Original Form: 35 core somatic symptom items, followed by 2 conditional filter questions assessing menstruation-associated symptom overlap for female respondents (totaling 37 items).
  • Revised Short Form (CSI-24): 24 core somatic items (marked with an asterisk in historical publications) representing the structurally optimized unidimensional version validated by Walker et al. (2009).
• Response Scale (Authentic 5-Point Likert Metric):
  • 0 = Mot at all [Not at all]
  • 1 = A little
  • 2 = Some
  • 3 = A lot
  • 4 = A whole lot
• Recall Period: Respondents rate how much each physical problem bothered them during the past two weeks.
• Scoring Rules:
  • Continuous Total Severity Score: The primary metric is calculated by summing the numerical ratings across all completed core items.
  • Total Possible Range (Original 35 items): 0 to 140 points. (Menstrual items 36 and 37 are qualitative/interpretive filters and are not summed into the primary core score).
  • Total Possible Range (CSI-24): 0 to 96 points.
  • Mean Item Score: Alternatively computed as the sum of items divided by the number of completed items (ranging from 0.0 to 4.0), facilitating direct cross-study comparisons when handling occasional missing data (standard protocol allows computing if $ge 80%$ of items are answered).
  • Dichotomous Symptom Count (Alternative Clinical Scoring): Items rated $ge 2$ (“Some”) or $ge 3$ (“A lot”) can be scored as 1 (clinically elevated symptom present) and 0 (absent/negligible) to yield a raw count of clinically significant symptoms.
• Interpretation & Clinical Benchmarks: Higher total scores reflect greater perceived somatic distress, sensory amplification, and functional disease burden. In pediatric chronic pain populations, CSI-24 scores exceeding 20 to 25 points indicate severe multisystem somatization requiring integrated interdisciplinary medical-behavioral intervention.

11. Permissions & Fee and Test Year

The Children’s Somatization Inventory was originally introduced in 1991 by Lynn S. Walker, Judy Garber, and Joseph W. Greene. The optimized revised form (CSI-24) was published in 2009 by Lynn S. Walker, Jane E. Beck, Judy Garber, and colleagues in the Journal of Pediatric Psychology.

Licensing and Fee Structure: The CSI and CSI-24 instruments are widely utilized in pediatric academic and medical environments. The scale items and scoring directions were published in the public domain for research and clinical use through peer-reviewed articles and clinical sourcebooks (e.g., Fischer & Corcoran, 2007, Measures for Clinical Practice and Research; PMC2722132). The authors and copyright holders grant permission for clinical, educational, and academic non-profit research utilization without licensing fees. Inquiries regarding commercial implementation, software integration, or formal written permission can be directed to the primary author, Dr. Lynn S. Walker, at Vanderbilt University Medical Center.

12. References

The following peer-reviewed publications document the empirical development, clinical application, and psychometric validation of the Children’s Somatization Inventory:

• Barsky, A. J., & Klerman, G. L. (1989). Overview: Somatosensory amplification and its role in somatoform disorders. Journal of Psychiatric Research, 23(2), 155–163. https://doi.org/10.1016/0022-3956(89)90022-1
• Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. https://doi.org/10.1126/science.847460
• Fischer, J., & Corcoran, K. J. (2007). Measures for Clinical Practice and Research: A Sourcebook (4th ed., Vol. 1, pp. 481–483). Oxford University Press.
• Garber, J., Walker, L. S., & Zeman, J. (1991). Somatization symptoms in a community sample of children and adolescents: Further validation of the Children’s Somatization Inventory. Psychological Assessment: A Journal of Consulting and Clinical Psychology, 3(4), 588–595. https://doi.org/10.1037/1040-3590.3.4.588
• Walker, L. S., Beck, J. E., Garber, J., & Lambert, W. (2009). Children’s Somatization Inventory: Psychometric properties of the revised form (CSI-24). Journal of Pediatric Psychology, 34(4), 430–440. https://doi.org/10.1093/jpepsy/jsn093
• Walker, L. S., Garber, J., & Greene, J. W. (1991). Somatization symptoms in pediatric abdominal pain patients: Relation to chronicity of abdominal pain and parent somatization. Journal of Abnormal Child Psychology, 19(4), 379–394. https://doi.org/10.1007/BF00919084
• Walker, L. S., Garber, J., & Greene, J. W. (1993). Psychosocial correlates of recurrent childhood pain: A comparison of pediatric patients with recurrent abdominal pain, organic illness, and psychiatric disorders. Journal of Abnormal Psychology, 102(2), 248–258. https://doi.org/10.1037/0021-843X.102.2.248
• Walker, L. S., Garber, J., Smith, C. A., & Claar, R. L. (2005). Testing a model of pain appraisal and coping in children with chronic abdominal pain. Health Psychology, 24(4), 364–374. https://doi.org/10.1037/0278-6133.24.4.364

13. Items of the Scale